Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.

Non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by providing a safer alternative to invasive techniques such as amniocentesis and chorionic villus sampling. NIPT detects chromosomal abnormalities through the analysis of cell-free fetal DNA (cffDNA) in maternal plasma. On...

Full description

Saved in:
Bibliographic Details
Main Authors: Zuzana Holesova, Jaroslav Budis, Marcel Kucharik, Juraj Gazdarica, Daria Carska, Gabriel Minarik, Michaela Hyblova, Tomas Szemes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327714
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850099807885983744
author Zuzana Holesova
Jaroslav Budis
Marcel Kucharik
Juraj Gazdarica
Daria Carska
Gabriel Minarik
Michaela Hyblova
Tomas Szemes
author_facet Zuzana Holesova
Jaroslav Budis
Marcel Kucharik
Juraj Gazdarica
Daria Carska
Gabriel Minarik
Michaela Hyblova
Tomas Szemes
author_sort Zuzana Holesova
collection DOAJ
description Non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by providing a safer alternative to invasive techniques such as amniocentesis and chorionic villus sampling. NIPT detects chromosomal abnormalities through the analysis of cell-free fetal DNA (cffDNA) in maternal plasma. One of the critical factors influencing accuracy of NIPT is the fetal fraction (FF) - the proportion of fetal cell-free DNA relative to total cell-free DNA in maternal plasma. This study investigates the potential of using telomere length measurements as a novel biomarker for fetal fraction prediction in NIPT. Telomere-derived fragments, which differ between maternal and fetal DNA, may serve as a measure of FF due to the distinct telomere length. Specifically, deviations from the expected shorter telomere lengths of maternal DNA toward longer lengths could be more pronounced at higher FF levels. Various models incorporating telomere content and features selected by Ordinary Least Squares (OLS) were evaluated to enhance fetal fraction prediction. Our results showed that telomere content also works as an independent predictor (with Pearson correlation 0.23), yielding a small improvement in prediction precision when combined with traditional models.
format Article
id doaj-art-d0fbd52abd7e423b83b668bf1cc97180
institution DOAJ
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d0fbd52abd7e423b83b668bf1cc971802025-08-20T02:40:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032771410.1371/journal.pone.0327714Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.Zuzana HolesovaJaroslav BudisMarcel KucharikJuraj GazdaricaDaria CarskaGabriel MinarikMichaela HyblovaTomas SzemesNon-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by providing a safer alternative to invasive techniques such as amniocentesis and chorionic villus sampling. NIPT detects chromosomal abnormalities through the analysis of cell-free fetal DNA (cffDNA) in maternal plasma. One of the critical factors influencing accuracy of NIPT is the fetal fraction (FF) - the proportion of fetal cell-free DNA relative to total cell-free DNA in maternal plasma. This study investigates the potential of using telomere length measurements as a novel biomarker for fetal fraction prediction in NIPT. Telomere-derived fragments, which differ between maternal and fetal DNA, may serve as a measure of FF due to the distinct telomere length. Specifically, deviations from the expected shorter telomere lengths of maternal DNA toward longer lengths could be more pronounced at higher FF levels. Various models incorporating telomere content and features selected by Ordinary Least Squares (OLS) were evaluated to enhance fetal fraction prediction. Our results showed that telomere content also works as an independent predictor (with Pearson correlation 0.23), yielding a small improvement in prediction precision when combined with traditional models.https://doi.org/10.1371/journal.pone.0327714
spellingShingle Zuzana Holesova
Jaroslav Budis
Marcel Kucharik
Juraj Gazdarica
Daria Carska
Gabriel Minarik
Michaela Hyblova
Tomas Szemes
Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
PLoS ONE
title Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
title_full Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
title_fullStr Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
title_full_unstemmed Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
title_short Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.
title_sort telomere length as a biomarker for fetal fraction prediction in non invasive prenatal testing
url https://doi.org/10.1371/journal.pone.0327714
work_keys_str_mv AT zuzanaholesova telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT jaroslavbudis telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT marcelkucharik telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT jurajgazdarica telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT dariacarska telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT gabrielminarik telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT michaelahyblova telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting
AT tomasszemes telomerelengthasabiomarkerforfetalfractionpredictioninnoninvasiveprenataltesting